Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
How can we create culturally competent workplaces for Muslim healthcare providers?
Muslim healthcare providers constitute a growing, diverse and underrepresented population in the U.S. Culturally...
Managing Congenital Adrenal Hyperplasia in the Amish Population
Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...